These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 7337470)

  • 21. [Experimental studies on the antiarrhythmic mechanism of mexiletine in guinea pig ventricular muscles using microelectrode techniques].
    Matsuo S
    Nihon Ika Daigaku Zasshi; 1984 Apr; 51(2):208-23. PubMed ID: 6330160
    [No Abstract]   [Full Text] [Related]  

  • 22. Investigation of the antifibrillatory activity of some anticonvulsant gamma-aminobutyric acid-transaminase inhibitors in the rabbit isolated heart: comparison with phenytoin and mexiletine.
    Almotrefi AA; Baker JB
    Br J Pharmacol; 1980; 71(2):635-9. PubMed ID: 7470766
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preferential action of mexiletine on central common pathway of reentrant ventricular tachycardia.
    Aizawa Y; Abe A; Ohira K; Furushima H; Chinushi M; Fujita S
    J Am Coll Cardiol; 1996 Dec; 28(7):1759-64. PubMed ID: 8962563
    [TBL] [Abstract][Full Text] [Related]  

  • 24. New antiarrhythmic drugs.
    Flaker GC; Munuswamy K
    Am Fam Physician; 1982 Nov; 26(5):226-32. PubMed ID: 7148632
    [No Abstract]   [Full Text] [Related]  

  • 25. [Mexiletine--findings in animal experiments on its antiarrhythmic and electrophysiological effects in the heart (author's transl)].
    Haap K; Antoni H
    Klin Wochenschr; 1978 Feb; 56(4):169-73. PubMed ID: 628200
    [No Abstract]   [Full Text] [Related]  

  • 26. [Cellular mechanism of the antiarrhythmic action of propranolol].
    Kwiatkowska B; Czarnecka M; Lewartowski B
    Acta Physiol Pol; 1970; 21(4):441-54. PubMed ID: 5452921
    [No Abstract]   [Full Text] [Related]  

  • 27. Does mexiletine have a preferential action (versus healthy myocardium) on the reentrant circuit of ventricular tachycardia?
    Abe A; Aizawa Y; Ma M
    Heart Vessels; 1997; Suppl 12():235-9. PubMed ID: 9476592
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of mexiletine on the electrophysical properties of the intact human heart.
    Harper RW; Olsson SB; Varnauskas E
    Scand J Clin Lab Invest; 1977 Oct; 37(6):503-7. PubMed ID: 616069
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effects of anti-arrhythmia agents of the heart conduction system].
    Kodama I; Anno T
    Nihon Rinsho; 1985 Nov; 43(11):2397-403. PubMed ID: 4087425
    [No Abstract]   [Full Text] [Related]  

  • 30. Effects of antiarrhythmic drugs on the repetitive extrasystole threshold and the ventricular fibrillation threshold.
    Murakawa Y; Toda I; Nozaki A; Kawakubo K; Sugimoto T
    Cardiology; 1989; 76(1):58-66. PubMed ID: 2468414
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effect of mexiletine on glucose and oxygen uptake in rat brain, liver and myocardial tissue in vitro (author's transl)].
    Moreno A; Rabadán F; Hidalgo A
    Rev Esp Fisiol; 1979 Sep; 35(3):317-20. PubMed ID: 504772
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mexiletine and tocainide: orally active congeners of lidocaine.
    Wulf BG
    Clin Pharm; 1983; 2(4):340-6. PubMed ID: 6411416
    [No Abstract]   [Full Text] [Related]  

  • 33. Hemodynamic, electrocardiographic and toxic effects of the intravenous administration of increasing doses of mexiletine in the dog. Comparison with similar effects produced by other antiarrhythmics.
    Carlier J
    Acta Cardiol Suppl; 1980; (25):81-100. PubMed ID: 6966456
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Hemodynamic and electrophysiological effects of intravenous injection of mexiletine].
    Tanaka T; Kusumoto M; Umemura J; Miyazawa Y; Suwa J; Komatsu Y
    Kokyu To Junkan; 1983 Dec; 31(12):1355-60. PubMed ID: 6676806
    [No Abstract]   [Full Text] [Related]  

  • 35. Baseline pharmacology, electrophysiology and pharmacokinetics of mexiletine.
    Middleton D
    Acta Cardiol Suppl; 1980; (25):45-53. PubMed ID: 6990666
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Quantitative study of the effect of lidocaine on the threshold for ventricular fibrillation in the dog.
    Gerstenblith G; Spear JF; Moore EN
    Am J Cardiol; 1972 Aug; 30(3):242-7. PubMed ID: 5044482
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effect of tricyclic antidepressants on automatism induced in the isolated rat ventricle: comparison of adrenergic beta-blockers and calcium antagonists].
    Laorden ML; Serrano JS
    Arch Farmacol Toxicol; 1983 Dec; 9(3):243-50. PubMed ID: 6143537
    [No Abstract]   [Full Text] [Related]  

  • 38. [Pharmacology of anti-arrhythmic agents (author's transl)].
    Hergueta G
    Folia Clin Int (Barc); 1975 Dec; 25(12):661-73. PubMed ID: 1220986
    [No Abstract]   [Full Text] [Related]  

  • 39. [Hemodynamic effects of a new anti-arrhythmia agent: mexiletine].
    Tomassetti V; Fontana F; Masi M; Mezzetti A; Poggiopollini G; Cuppini A; Cuccurullo F
    Boll Soc Ital Cardiol; 1980; 25(1):95-100. PubMed ID: 7236434
    [No Abstract]   [Full Text] [Related]  

  • 40. Observations of the haemodynamics of mexiletine.
    Banim SO; Da Silva A; Stone D; Balcon R
    Postgrad Med J; 1977; 53 Suppl 1():74-7. PubMed ID: 876956
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.